<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/2179308/open_sms">Send us a text</a>Peter Lio, MD, Assistant Professor of Clinical Dermatology and Pediatrics at Northwestern University’s Feinberg School of Medicine, discusses the development of JAK inhibitors over the years, and reviews the increase in reliability among both oral and topical treatments for atopic dermatitis.

Send us a text Peter Lio, MD, Assistant Professor of Clinical Dermatology and Pediatrics at Northwestern University’s Feinberg School of Medicine, discusses the development of JAK inhibitors over the years, and reviews the increase in reliability among both oral and topical treatments for atopic dermatitis.

<a href="https://www.buzzsprout.com/twilio/text_messages/2179308/open_sms" rel="noopener noreferrer">Send us a text</a>Peter Lio, MD, Assistant Professor of Clinical Dermatology and Pediatrics at Northwestern University’s Feinberg School of Medicine, discusses the development of JAK inhibitors over the years, and reviews the increase in reliability among both oral and topical treatments for atopic dermatitis.

Peter Lio, MD: The Evolution of Topical JAK Inhibitors

JCAD's audio platform provides interviews with leading experts in the dermatology field.&nbsp;

Medicine

Health & Fitness

JCAD's audio platform provides interviews with leading experts in the dermatology field. 

Share Peter Lio, MD: The Evolution of Topical JAK Inhibitors

Sign up to save your podcasts

Peter Lio, MD: The Evolution of Topical JAK Inhibitors

Peter Lio, MD: The Evolution of Topical JAK Inhibitors

More shows like The Journal of Clinical and Aesthetic Dermatology

Emergency Medicine Cases

EADV Podcast

Derms on Drugs